The effect of Vitamin D on Platelet elevation

The effect of Vitamin D on platelet elevation in patients with Idioprotective Thrombocytopenic Purpura (ITP)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181003041223N1

Enrollment

Registered

2018-11-12

Start date

2017-08-23

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Thrombocytopenic Purpura (ITP). Idiopathic thrombocytopenic purpura

Interventions

The intervention group received 8 weeks of vitamin D at a dose of 50000U / week, and platelet and vitamin D levels were checked at the end of 8 weeks..

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: Informed consent of patients to participate in the Study Patients with Idioprotective Thrombocytopenic Purpura (ITP) with platelets of 50000-100000 with less than 30mg / dl of vitamin D that did not received any treatment New ITP patients with Vitamin D of less than 30mg / dl who lost platelets within the range of 50,000 to 100,000 when the dose of corticosteroid was reducing.

Exclusion criteria

Exclusion criteria: Patients who are at risk for Vitamin D toxicity and are initially high in Vit D. Pregnant women People with Chronic Kidney Disease (CKD) and Hyperparathyroidism, as identified by the tests at the beginning of the study.

Design outcomes

Primary

Measure	Time frame
V??itamin D. Timepoint: Before beginning the study and two months after receiving vitamin D. Method of measurement: Laboratory Kit.;?Blood Urea Nitrogen (BUN). Timepoint: Before beginning the study. Method of measurement: Laboratory Kit.;Creatinine (Cr). Timepoint: Before beginning the study. Method of measurement: Laboratory Kit.;Alkaline Phosphatase (ALP). Timepoint: Before beginning the study. Method of measurement: Laboratory Kit.;Calcium (Ca). Timepoint: Before beginning the study. Method of measurement: Laboratory Kit.;Parathyroid hormone(PTH). Timepoint: Before beginning the study. Method of measurement: Laboratory Kit.;Platelet. Timepoint: Before beginning the study and two months after receiving vitamin D. Method of measurement: Laboratory Kit.	—

Measure

Time frame

V??itamin D. Timepoint: Before beginning the study and two months after receiving vitamin D. Method of measurement: Laboratory Kit.;?Blood Urea Nitrogen (BUN). Timepoint: Before beginning the study. Method of measurement: Laboratory Kit.;Creatinine (Cr). Timepoint: Before beginning the study. Method of measurement: Laboratory Kit.;Alkaline Phosphatase (ALP). Timepoint: Before beginning the study. Method of measurement: Laboratory Kit.;Calcium (Ca). Timepoint: Before beginning the study. Method of measurement: Laboratory Kit.;Parathyroid hormone(PTH). Timepoint: Before beginning the study. Method of measurement: Laboratory Kit.;Platelet. Timepoint: Before beginning the study and two months after receiving vitamin D. Method of measurement: Laboratory Kit.

—

Secondary

Measure	Time frame
Platelet. Timepoint: Before beginning the study and two months after receiving vitamin D. Method of measurement: Laboratory Kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahrokh Fargah

Ahvaz University of Medical Sciences

drbabakalaviyan1360@gmail.com+98 61 3332 3221

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026